14-77283714-T-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_013382.7(POMT2):​c.1653+83A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.532 in 1,177,070 control chromosomes in the GnomAD database, including 168,817 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.52 ( 21034 hom., cov: 32)
Exomes 𝑓: 0.53 ( 147783 hom. )

Consequence

POMT2
NM_013382.7 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -1.77

Publications

8 publications found
Variant links:
Genes affected
POMT2 (HGNC:19743): (protein O-mannosyltransferase 2) The protein encoded by this gene is an O-mannosyltransferase that requires interaction with the product of the POMT1 gene for enzymatic function. The encoded protein is found in the membrane of the endoplasmic reticulum. Defects in this gene are a cause of Walker-Warburg syndrome (WWS).[provided by RefSeq, Oct 2008]
POMT2 Gene-Disease associations (from GenCC):
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • myopathy caused by variation in POMT2
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2
    Inheritance: AR Classification: MODERATE Submitted by: Ambry Genetics
  • autosomal recessive limb-girdle muscular dystrophy type 2N
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital muscular dystrophy with cerebellar involvement
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital muscular dystrophy with intellectual disability
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • muscle-eye-brain disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 14-77283714-T-G is Benign according to our data. Variant chr14-77283714-T-G is described in ClinVar as Benign. ClinVar VariationId is 670967.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.551 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_013382.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POMT2
NM_013382.7
MANE Select
c.1653+83A>C
intron
N/ANP_037514.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POMT2
ENST00000261534.9
TSL:1 MANE Select
c.1653+83A>C
intron
N/AENSP00000261534.4
POMT2
ENST00000682795.1
c.1653+83A>C
intron
N/AENSP00000507574.1
POMT2
ENST00000682247.1
c.1653+83A>C
intron
N/AENSP00000507213.1

Frequencies

GnomAD3 genomes
AF:
0.523
AC:
79393
AN:
151806
Hom.:
21016
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.485
Gnomad AMI
AF:
0.572
Gnomad AMR
AF:
0.454
Gnomad ASJ
AF:
0.484
Gnomad EAS
AF:
0.473
Gnomad SAS
AF:
0.474
Gnomad FIN
AF:
0.617
Gnomad MID
AF:
0.487
Gnomad NFE
AF:
0.556
Gnomad OTH
AF:
0.510
GnomAD4 exome
AF:
0.534
AC:
546951
AN:
1025146
Hom.:
147783
AF XY:
0.532
AC XY:
281651
AN XY:
529048
show subpopulations
African (AFR)
AF:
0.482
AC:
12002
AN:
24886
American (AMR)
AF:
0.387
AC:
17084
AN:
44120
Ashkenazi Jewish (ASJ)
AF:
0.485
AC:
11361
AN:
23404
East Asian (EAS)
AF:
0.486
AC:
18255
AN:
37590
South Asian (SAS)
AF:
0.466
AC:
36032
AN:
77356
European-Finnish (FIN)
AF:
0.609
AC:
32123
AN:
52730
Middle Eastern (MID)
AF:
0.441
AC:
2058
AN:
4670
European-Non Finnish (NFE)
AF:
0.552
AC:
394110
AN:
714222
Other (OTH)
AF:
0.518
AC:
23926
AN:
46168
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
13834
27668
41503
55337
69171
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8670
17340
26010
34680
43350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.523
AC:
79447
AN:
151924
Hom.:
21034
Cov.:
32
AF XY:
0.523
AC XY:
38834
AN XY:
74256
show subpopulations
African (AFR)
AF:
0.485
AC:
20067
AN:
41396
American (AMR)
AF:
0.453
AC:
6919
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.484
AC:
1681
AN:
3470
East Asian (EAS)
AF:
0.475
AC:
2448
AN:
5156
South Asian (SAS)
AF:
0.474
AC:
2282
AN:
4810
European-Finnish (FIN)
AF:
0.617
AC:
6516
AN:
10554
Middle Eastern (MID)
AF:
0.483
AC:
141
AN:
292
European-Non Finnish (NFE)
AF:
0.556
AC:
37788
AN:
67952
Other (OTH)
AF:
0.515
AC:
1087
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1944
3888
5831
7775
9719
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
700
1400
2100
2800
3500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.536
Hom.:
58858
Bravo
AF:
0.506
Asia WGS
AF:
0.494
AC:
1716
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
0.082
DANN
Benign
0.34
PhyloP100
-1.8
PromoterAI
-0.0053
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2216089; hg19: chr14-77750057; COSMIC: COSV55072374; COSMIC: COSV55072374; API